Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep.
Mucosal delivery of CpG oligodeoxynucleotide (ODN) in mice has been shown to induce potent innate immunostimulatory responses and protection against infection. We evaluated the efficacy of CpG ODN in stimulating systemic innate immune responses in sheep following delivery to the pulmonary mucosa. Intrapulmonary (IPM) administration of B-Class CpG ODN in saline induced transient systemic responses which included increased rectal temperatures, elevated serum 2'5'-A synthetase and haptoglobin concentrations. The ODN dose required to induce detectable systemic responses following IPM delivery could be reduced by approximately 80% if the CpG ODN was administered in 30% emulsigen instead of saline. Intrapulmonary B-Class CpG ODN formulated in 30% emulsigen produced similar effects when compared to those seen following SC injection. These responses were CpG ODN-specific since control GpC ODN did not induce any detectable response. Intrapulmonary administration of both B-Class and the newly described C-Class CpG ODN produced similar effects indicating that both classes of CpG ODN were comparably effective in stimulating innate immune system following mucosal delivery. Administration of CpG ODN directly into the lungs or delivery of CpG ODN via an intratracheal (IT) infusion also produced similar systemic responses. These observations support the conclusion that mucosal delivery of CpG ODN is an effective route for induction of systemic acute phase responses and antiviral effector molecules in large animals, and may be helpful in controlling systemic infections.
Nichani
Anil K
AK
Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E3, Canada.
Dar
M Arshud
MA
Krieg
Arthur M
AM
Mirakhur
Kuldip K
KK
Kaushik
Radhey S
RS
Griebel
Philip J
PJ
Manuja
Anju
A
Townsend
Hugh G G
HG
Babiuk
Lorne A
LA
Mutwiri
George K
GK
D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood; D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D001831:Body Temperature; D006242:Haptoglobins / Q000378:metabolism; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology; D008297:Male; D009838:Oligodeoxyribonucleotides / Q000276:immunology / Q000494:pharmacology*; D020545:Respiratory Mucosa / Q000276:immunology*; D012756:Sheep / Q000276:immunology*
D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D006242:Haptoglobins; D009838:Oligodeoxyribonucleotides; D015088:2',5'-Oligoadenylate Synthetase